 VICTORIA, British Columbia--BUSINESS WIRE--- IPA Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. the Company or IPA NASDAQ: IPA TSX VENTURE: IPA a leader in full-service, therapeutic antibody discovery and development, today announces the promotion of Dr. Barry Duplantis, Ph.D., to VP of Client Relations and welcomes Ms. Carla Dahl as VP of Marketing. Dr. Duplantis, who joined the Company in 2018, was previously ImmunoPrecises Director of Client Relations, where he was responsible for client interactions 